Professor Colin Baigent
Professor of Epidemiology and Director, MRC PHRU
- Deputy Director, CTSU
Colin Baigent studied Medicine at Bristol and Oxford University (1983-89), having originally studied Mathematics at Oxford (1980-83).
He became an MRC career scientist in 2002, and in 2006 was appointed Professor of Epidemiology at Oxford. From July 2013, he became Deputy Director of CTSU.
His main interest is in cardiovascular epidemiology, and most particularly the design, conduct and application of large-scale randomised trials in cardiovascular disease. His research includes the coordination of meta-analyses of randomised trials, typically with individual participant data, resulting in landmark papers that have helped determine the effects of aspirin (and other antiplatelet drugs), non-steroidal anti-inflammatory drugs, fibrinolytic therapy, and statins in different types of patients. His group has also contributed to a better understanding of cardiovascular disease in patients with renal impairment through the Study of Heart and Renal Protection (SHARP), the largest ever in patients with moderate-to-severe chronic kidney disease (CKD), recruiting 9438 patients in nearly 400 hospitals in 18 countries.
Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapy.
Storey BC. et al, (2018), Kidney Int, 93, 1165 - 1174
Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation.
Storey BC. et al, (2018), Kidney Int, 93, 1000 - 1007
Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials.
Scally B. et al, (2018), Lancet Gastroenterol Hepatol, 3, 231 - 241
The role of lipoprotein (a) in chronic kidney disease.
Hopewell JC. et al, (2018), J Lipid Res, 59, 577 - 585
Effect of diabetes duration and glycaemic control on 14-year cause-specific mortality in Mexican adults: a blood-based prospective cohort study.
Herrington WG. et al, (2018), Lancet Diabetes Endocrinol